Skip to main content

Table 1 Prevalence (%) of Gene X-pert Rifampicin Resistance (RR) among TB positive cases

From: Prevalence of Rifampicin resistance tuberculosis among presumptive tuberculosis patients in Egypt-2021: a national health facility-based survey

Method of Calculation

Prevalence of RR (95% CI)

All TB patients

N = 676

New Patients

N = 603

Retreated Patients

N = 73

Crude analysis

3.99 (2.51–5.47)

3.32 (1.88– 4.75)

9.59 (2.67–16.51)

Cluster analysis*

5.01 (2.90–7.13)

4.09 (2.18–5.99)

8.48 (0.0–17.49)

Weighted analysis

 

3.84 (2.28–5.38)

 
  1. * The prevalence and 95%CI were calculated according to clusters
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us